logo/base Created with Sketch.

FibroScan® probes

Because each patient has a different morphology, choose the appropriated FibroScan® S+, M+ or XL+ probe to get the best FibroScan® performance.

wave

Optimize measurement accuracy

FibroScan® offers a range of 3 probes (S+, M+ and XL+) designed to fit patient morphology.  

By adjusting the measurement area relative to the distance between the probe and the liver (Probe to Capsula Distance) a consistent explored volume can be maintained.

For M+ and XL+ probes, FibroScan® automatically recommends the right probe.

Which FibroScan® probe is adapted to your patient?

FibroScan® S+ Probe

FibroScan® M+ Probe

FibroScan® XL+ Probe

For thin patients

Designed for being placed into narrow intercostal space

For standard morphotype’s patients

For overweight patients

Designed to enhance

signal penetration through deeper tissues

Measurement depth

From 15 to 50 mm

Measurement depth

From 25 to 65 mm

From 25 to 70 mm with SmartExam

Measurement depth

From 35 to 75 mm

From 35 to 85 mm with SmartExam

Criteria of selection

Age < 18yo

and Thoracic Perimeter ≤ 75 cm

 

Criteria of selection

Age < 18yo and
Thoracic Perimeter > 75 cm

or
Age ≥ 18yo and no XL+ probe recommendation

Criteria of selection

Age ≥ 18yo

and no M+ probe recommendation

 

FibroScan® comes with the standard FibroScan® M+ probe.

FibroScan® S+ and FibroScan® XL+ probes are available as an option.

What our users say

quote

The obese population that we receive for FibroScan® examinations has increased substantially in recent years. CAP™ has become essential to our prescribers to precisely monitor patient’s steatosis.

FibroScan® nurse referent | Cochin University Hospital, Paris, France

chevron chevron

FibroScan® Indications for Use
The FibroScan® family of products is intended to provide shear wave speed measurements and estimates of tissue stiffness as well as ultrasound coefficient of attenuation (CAP: Controlled Attenuation Parameter) in internal structures of the body. The Shear wave speed and stiffness measurements may be used as an aid to clinical management of adult patients with liver disease. The FibroScan® family of products is indicated for non-invasive measurement in the liver of 50 Hz shear wave speed and estimates of stiffness as well as determining a 3.5 MHz ultrasound coefficient of attenuation (CAP: Controlled Attenuation Parameter). The shear wave speed and stiffness, and CAP may be used as an aid to diagnosis and monitoring of adult patients with liver disease, as part of an overall assessment of the liver. Shear wave speed and stiffness, and CAP* may be used as an aid in the clinical management of pediatric patients with liver disease. The FibroScan®  family of products is also indicated for noninvasive measurement in the spleen of 100 Hz shear wave speed and estimates of stiffness that may be used as an aid to diagnosis, monitoring and clinical management of adult patients with liver disease, as part of an overall assessment of the liver.
* CAP for pediatric patients with liver disease is only available with SmartExam capability.